• Apostolopoulos V, Xiang S D, Selomulya C. Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles[J]. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2010, 2(3): 205-218. doi: 10.1002/wnan.88

  • Bozkir A, Saka O M. Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics[J]. Drug Deliv, 2004, 11(): 107-112. doi: 10.1080/10717540490280705

  • Centelles M N, Qian C, Campanero M A. New methodologies to characterize the effectiveness of the gene transfer mediated by DNA-chitosan nanoparticles[J]. Int J Nanomed, 2008, 3(4): 451-460.

  • Chinsangaram J, Beard C, Mason P W. Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins[J]. J Virol, 1998, 72(): 4454-4457.

  • Doel T R. FMD Vaccines[J]. Virus Res, 2003, 91(): 81-89. doi: 10.1016/S0168-1702(02)00261-7

  • Hashimoto M, Morimoto M, Saimoto H. Gene transfer by DNA/mannosylated chitosan complexes into mouse peritoneal macrophages[J]. Biotechnol Lett, 2006, 28(): 815-821. doi: 10.1007/s10529-006-9006-x

  • Jang M K, Jeong Y I, Cho C S. The preparation and characterization of low molecular and water soluble free-amine chitosan[J]. Bull Korean Chem Soc, 2002, 23(): 914-916. doi: 10.5012/bkcs.2002.23.6.914

  • Jiang H L, Kang M L, Quan J S. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization[J]. Biomaterials, 2008, 29(): 1931-1939. doi: 10.1016/j.biomaterials.2007.12.025

  • Jiang L, Qian F, He X. Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice[J]. J Gene Med, 2007, 9(): 253-264. doi: 10.1002/(ISSN)1521-2254

  • Kim T H, Jin H, Kim H W. Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells[J]. Mol Cancer Ther, 2006, 5(): 1723-1732. doi: 10.1158/1535-7163.MCT-05-0540

  • Lu S, Song X, Cao D. Preparation of Water-Soluble Chitosan[J]. J Appl Polymer Sci, 2004, 91(): 3497-3503. doi: 10.1002/(ISSN)1097-4628

  • McCullough K C, Sobrino F. 2004. Immunology of Foot and Mouth Disease. In: Foot and Mouth Disease current perspectives. Sobrino F, Domingo E, Ed. England: Horizon Bioscience, pp173-222.

  • Mady M M, Darwish M M, Khalil S. Biophysical studies on chitosan coated liposomes[J]. Eur Biophysic J, 2009, 38(): 1127-1133. doi: 10.1007/s00249-009-0524-z

  • OIE Manual. 2008. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter No. 2. 1. 5. (Revised version May 2012), 6th Edition, Volume 1 and 2.

  • Reed L J, Muench H A. A simple method of estimating 50% end points[J]. Am J Hyg, 1938, 27(): 493-497.

  • Tan M C, Mommaas A M, Drijfhout J W. Mannose receptor-mediated uptake of antigens strongly enhances HLA class Ⅱ-restricted antigen presentation by cultured dendritic cells[J]. Eur J Immunol, 1997, 27(): 2426-2435. doi: 10.1002/(ISSN)1521-4141

  • Zhao F, Wu Y, Zhang X, et al.2011. Enhanced immune response and protective efficacy of a Treponema pallidum Tp92 DNA vaccine vectored by chitosan nanoparticles and adjuvanted with IL-2. Hum Vaccine. 1: 7(10).